Tandem Diabetes Care Inc (TNDM)
37.49
+0.44
(+1.19%)
USD |
NASDAQ |
Jan 08, 16:00
37.89
+0.40
(+1.07%)
After-Hours: 04:37
Tandem Diabetes Care SG&A Expense (Quarterly): 99.64M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insulet Corp | 234.10M |
| Haemonetics Corp | 106.95M |
| Masimo Corp | 184.80M |
| Globus Medical Inc | 240.74M |
| Perspective Therapeutics Inc | 6.975M |